RecruitingNCT07039149
Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Dual Antiplatelet Agents Therapy in the Emergency Department for Acute Coronary Syndrome (The DATES Study).
Sponsor
Jordan Collaborating Cardiology Group
Enrollment
200 participants
Start Date
Aug 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adult patients
- Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
- Antiplatelet medication (s) prescribed during index admission to hospital.
- Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
Exclusion Criteria3
- Non cardiac chest pain.
- No administration of antiplatelet agents during hospitalization.
- Refusal of contact for follow up.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07039149